Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes.
Van Pelt, R E
Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes. [electronic resource] - Obesity (Silver Spring, Md.) Apr 2014 - 1024-31 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1930-739X
10.1002/oby.20653 doi
Adiposity--drug effects
Aged
Blood Glucose--metabolism
Body Composition--drug effects
Energy Metabolism
Estrogen Replacement Therapy
Estrogens--pharmacology
Exercise
Female
Humans
Insulin--blood
Lipids--blood
Middle Aged
Obesity--metabolism
Postmenopause--blood
Raloxifene Hydrochloride--pharmacology
Selective Estrogen Receptor Modulators--pharmacology
Treatment Outcome
Weight Loss--drug effects
Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes. [electronic resource] - Obesity (Silver Spring, Md.) Apr 2014 - 1024-31 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1930-739X
10.1002/oby.20653 doi
Adiposity--drug effects
Aged
Blood Glucose--metabolism
Body Composition--drug effects
Energy Metabolism
Estrogen Replacement Therapy
Estrogens--pharmacology
Exercise
Female
Humans
Insulin--blood
Lipids--blood
Middle Aged
Obesity--metabolism
Postmenopause--blood
Raloxifene Hydrochloride--pharmacology
Selective Estrogen Receptor Modulators--pharmacology
Treatment Outcome
Weight Loss--drug effects